Inflammation and the emerging role of the toll-like receptor system in acute brain ischemia

Stroke

Volumn 40, Issue 3 SUPPL. 1, 2009, Pages

  Marsh, Brenda J ^a   Stevens, Susan L ^a   Hunter, Brian ^a   Stenzel Poore, Mary P ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Hypoxia ischemia; Inflammation; Stroke

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; INTERLEUKIN 12; RNA; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN BLOOD FLOW; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; IMMUNE SYSTEM; INFLAMMATION; LASER DOPPLER FLOWMETRY; LEUKOCYTE; MICROARRAY ANALYSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NATURAL KILLER CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STROKE; TRANSCRIPTION REGULATION;

ACUTE DISEASE; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BRAIN ISCHEMIA; CEREBRAL ARTERIES; DINUCLEOSIDE PHOSPHATES; DISEASE MODELS, ANIMAL; ENCEPHALITIS; GATA3 TRANSCRIPTION FACTOR; INTERFERON TYPE I; ISCHEMIC PRECONDITIONING; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED C57BL; STROKE; TOLL-LIKE RECEPTORS;

EID: 61849113405     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.534917     Document Type: Conference Paper

References (17)

1. Broad A, kirby JA, Jones DE. Toll-like receptor interactions: Tolerance of Myd88-dependent cytokines but enhancement of Myd88-independent interferon-beta production. Immunology. 2007;120:103-111
2. Rice L, Orlow D, Ceonzo K, Stahl GL, Tzianabos AO, Wada H, Aird WC, Buras JA. CpG oligodeoxynucleotide protection in polymicrobial sepsis is dependent on interleukin-17. J Infect Dis. 2005;191:1368-1376.
3. Stevens SL, Ciesielski TM, Marsh BJ, Yang T, Homen DS, Boule JL, Lessov NS, Simon RP, Stenzel-Poore MP. Toll-like receptor 9: a new target of ischemic preconditioning in the brain. J Cereb Blood Flow Metab. 2008;28:1040-1047.
4. Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S, Svenningsson A, Linda H, van Der Meide PH, Cullheim S, Olsson T, Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci. 2000;20:5283-5291.
5. Boccaccio GL, Mor F, Steinman L. Non-coding plasmid DNA induces IFN-gamma in vivo and suppresses autoimmune encephalomyelitis. Int Immunol. 1999;11:289-296.
6. Wu HJ, Sawaya H, Binstadt B, Brickelmaier M, Blasius A, Gorelik L, Mahmood U, Weissleder R, Carulli J, Benoist C, Mathis D. Inflammatory arthritis can be reined in by CpG-induced CD-NK cell cross tatk. J Exp Med. 2007;204:1911-1922.
7. Veldhuis WB, Floris S, van der Meide PH, Vos IM, de Vries HE, Dijkstra CD, Bar PR, Nicolay K. Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption. J Cereb Blood Flow Metab. 2003;23:1060-1069.
8. Bosca L, Bodelon OG, Hortelano S, Casellas A, Bosch F. Anti-inflammatory action of Type I interferons deduced from mice expressing interferon beta. Gene Ther. 2000;7:817-825.
9. Jin S, Kawanokuchi J, Mizuno T, Wang J, Sonobe Y, Takeuchi H, Suzumura A. Interferon-beta is neuroprotective against the toxicity induced by activated microglia. Brain Res. 2007;1179:140-146.
10. Liu H, Xin L, Chan BPL, Teoh R, Tang BL, Tan YH. Interferon beta administration confers a beneficial outcome in a rabbit model of thromboembolic cerebral ischemia. Neurosci Lett. 2002;327:146-148.
11. Veldhuis W, Derksen J, Floris S, van der Meide P, de Vries H, Schepers J, Vos I, Dijkstra C, Rappelle L, Nicolay K, Bar P. Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat. J Cereb Blood Flow Metab. 2003;23:1029-1039.
12. Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation. 2007;115:1599-1608.
13. Delia Chiesa M, Romagnani C, Thiel A, Moretta L, Moretta A. Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses. Blood. 2006;108:3851-3858.
14. Gerosa F, Gobbi A, Zorzi P, Burg S, Briere F, Carra G, Trinchieri G. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol. 2005;174:727-734.
15. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, Chu X, Simon RP. Effect of ischemic preconditioning on genomic response to cerebral ischemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet. 2003;362:1028-1037.
16. Stenzel-Poore MP, Stevens SL, King JS, Simon RP. Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis. Stroke. 2007;38:680-685.
17. Clark WM, Lessov NS, Dixon MP, Eckenstein F. Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res. 1997;19:641-648.